Search research articles
Contact Us
Filters
Showing results (381-390 of 442) with videos related to
Page
of 45
Sort By:
Science Translational Medicine
|
March 11, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value
Carolina Reduzzi, Eleonora Nicolò, Lorenzo Gerratana, et al.
JCO Precision Oncology
|
May 4, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis
Lorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
The Journal of Clinical Investigation
|
September 16, 2025
Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis
David Scholten, Lamiaa El-Shennawy, Yuzhi Jia, et al.
JNCI Cancer Spectrum
|
August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis
Francesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2005
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
Marjorie C Green, Aman U Buzdar, Terry Smith, et al.
Cells
|
September 23, 2022
MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer
Maroua Manai, Ines ELBini-Dhouib, Pascal Finetti, et al.
Springerplus
|
October 9, 2013
Presence of anaplastic lymphoma kinase in inflammatory breast cancer
Fredika M Robertson, Emanuel F Petricoin Iii, Steven J Van Laere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Whitney L Hensing, Lorenzo Gerratana, Katherine Clifton, et al.
The Journal of Clinical Investigation
|
March 26, 2024
Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers
Yueming Zhu, Anupam Banerjee, Ping Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2018
Anaplastic Lymphoma Kinase Mutation (<i>ALK</i> F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to Alectinib
Benedito A Carneiro, Sahithi Pamarthy, Ami N Shah, et al.
Page
of 45
Search research articles
Search
Showing results (381-390 of 442) with videos related to
Sort By:
Page
of 45
Science Translational Medicine
|
March 11, 2026
Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value
Carolina Reduzzi, Eleonora Nicolò, Lorenzo Gerratana, et al.
JCO Precision Oncology
|
May 4, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis
Lorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
The Journal of Clinical Investigation
|
September 16, 2025
Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis
David Scholten, Lamiaa El-Shennawy, Yuzhi Jia, et al.
JNCI Cancer Spectrum
|
August 12, 2025
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis
Francesco Schettini, Sabrina Nucera, Giuseppe Di Grazia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2005
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks
Marjorie C Green, Aman U Buzdar, Terry Smith, et al.
Cells
|
September 23, 2022
MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer
Maroua Manai, Ines ELBini-Dhouib, Pascal Finetti, et al.
Springerplus
|
October 9, 2013
Presence of anaplastic lymphoma kinase in inflammatory breast cancer
Fredika M Robertson, Emanuel F Petricoin Iii, Steven J Van Laere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Whitney L Hensing, Lorenzo Gerratana, Katherine Clifton, et al.
The Journal of Clinical Investigation
|
March 26, 2024
Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers
Yueming Zhu, Anupam Banerjee, Ping Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 22, 2018
Anaplastic Lymphoma Kinase Mutation (<i>ALK</i> F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to Alectinib
Benedito A Carneiro, Sahithi Pamarthy, Ami N Shah, et al.
Page
of 45